search
for
 About Bioline  All Journals  Testimonials  Membership  News


Iranian Journal of Pharmacology and Therapeutics
Razi Institute for Drug Research (RIDR) of Iran University of Medical Sciences and Health Services (IUMS)
ISSN: 1735-2657
Vol. 5, No. 2, 2006, pp. 167-169
Bioline Code: pt06029
Full paper language: English
Document type: Research Article
Document available free of charge

Iranian Journal of Pharmacology and Therapeutics, Vol. 5, No. 2, 2006, pp. 167-169

 en Diuretic Activity of Sufoof-e-Suzak Qawi an Unani Polyherbomineral Formulation
Krishna, K.L. & Agrawal, S.S.

Abstract

The Suffof-e-Suzak Qawi is an unani polyherbomineral formulation and is being used in the alternative system of medicine for its anti-gonorrheal and diuretic activity. It is an official monograph in national formulary of unani medicine (NFUM) and reported as anti-gonorrheal and diuretic. The aqueous suspension of the formulation was studied for its possible diuretic activity and its effect on urinary sodium and potassium excretion. The results were compared with animal groups treated with vehicle and standard drug furosemide. When tested in healthy adult rats the formulation at a dose of 500, 750 and 1000 mg/kg has shown increase in the urinary output and urinary sodium excretion but not any increase in the urinary potassium excretion at all dose levels. The present study showed that, the aqueous suspension of Suffof-e-Suzak Qawi has diuretic activity comparable with the standard drug furosemide in producing urinary output and urinary sodium excretion and has no effect on urinary potassium excretion.

Keywords
Saluretric, Diuretic, ISM & H, Alternative system of medicine, Unani

 
© Copyright 2006 - Razi Institute for Drug Research (RIDR)
Alternative site location: http://ijpt.iums.ac.ir/

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil